As of the latest SEC filings, Veradermics, Inc (MANE) is held by 45 institutional funds. The largest fund shareholder is VANGUARD TOTAL STOCK MARKET INDEX FUND (VTI), holding an estimated $31,872,183.90 in market value, representing a significant portion of its portfolio.
Funds holding Veradermics, Inc (MANE)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- MANE
- CIK:
- 0001827635
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $31,872,183.90 | 504,706 | Mar 31, 2026 | May 28, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 1.38% | $30,085,859.85 | 476,419 | Mar 31, 2026 | May 29, 2026 |
|
FGCKX
Fidelity Growth Company Fund
|
MF | Fidelity | 0.03% | $27,058,927.70 | 590,162 | Feb 28, 2026 | Apr 24, 2026 |
|
THQ
abrdn Healthcare Opportunities Fund
|
CEF | abrdn / Aberdeen | 3.09% | $22,285,571.85 | 352,899 | Mar 31, 2026 | May 29, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.92% | $21,830,449.80 | 345,692 | Mar 31, 2026 | May 29, 2026 |
|
THQ
abrdn Healthcare Opportunities Fund
|
CEF | abrdn / Aberdeen | 2.39% | $17,256,432.15 | 273,261 | Mar 31, 2026 | May 29, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 1.39% | $15,777,332.85 | 249,839 | Mar 31, 2026 | May 29, 2026 |
|
FWAFX
Fidelity Worldwide Fund
|
MF | Fidelity | 0.35% | $13,266,000.00 | 134,000 | Apr 30, 2026 | Jun 26, 2026 |
|
THW
abrdn World Healthcare Fund
|
CEF | abrdn / Aberdeen | 2.63% | $12,658,164.90 | 200,446 | Mar 31, 2026 | May 29, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.01% | $11,279,032.05 | 178,607 | Mar 31, 2026 | May 28, 2026 |
|
FFGRX
Emerald Growth Fund
|
MF | Independent / Boutique | 0.71% | $10,029,294.00 | 101,306 | Apr 30, 2026 | Jun 22, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.75% | $9,827,592.45 | 155,623 | Mar 31, 2026 | May 29, 2026 |
|
VSCCX
JPMorgan Small Cap Blend Fund
|
MF | JPMorgan | 0.67% | $9,627,596.40 | 152,456 | Mar 31, 2026 | May 29, 2026 |
|
THW
abrdn World Healthcare Fund
|
CEF | abrdn / Aberdeen | 1.95% | $9,367,797.30 | 148,342 | Mar 31, 2026 | May 29, 2026 |
|
FGKFX
Fidelity Growth Company K6 Fund
|
MF | Fidelity | 0.03% | $7,712,474.35 | 168,211 | Feb 28, 2026 | Apr 24, 2026 |
|
FCGSX
Fidelity Series Growth Company Fund
|
MF | Fidelity | 0.03% | $6,955,995.20 | 151,712 | Feb 28, 2026 | Apr 24, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 1.23% | $6,902,610.75 | 109,305 | Mar 31, 2026 | May 29, 2026 |
|
FACTX
Fidelity Advisor Health Care Fund
|
MF | Fidelity | 0.21% | $5,940,000.00 | 60,000 | Apr 30, 2026 | Jun 26, 2026 |
|
PGRTX
SmallCap Growth Fund I
|
MF | Independent / Boutique | 0.25% | $5,877,729.00 | 59,371 | Apr 30, 2026 | Jun 25, 2026 |
|
FBTDX
Franklin Biotechnology Discovery Fund
|
MF | Franklin Templeton | 0.52% | $5,336,496.00 | 53,904 | Apr 30, 2026 | Jun 24, 2026 |
|
FSAKX
Strategic Advisers U.S. Total Stock Fund
|
MF | Fidelity | 0.00% | $3,741,360.00 | 81,600 | Feb 28, 2026 | Apr 24, 2026 |
|
CZMSX
Multi-Manager Small Cap Equity Strategies Fund
|
MF | Columbia Threadneedle | 0.26% | $3,163,053.95 | 68,987 | Feb 28, 2026 | Apr 27, 2026 |
|
-
Brighthouse/Wellington Large Cap Research Portfolio
|
ETF | Independent / Boutique | 0.09% | $2,004,633.60 | 31,744 | Mar 31, 2026 | May 28, 2026 |
|
-
LVIP Baron Growth Opportunities Fund
|
ETF | Independent / Boutique | 0.25% | $1,563,594.00 | 24,760 | Mar 31, 2026 | May 18, 2026 |
|
ITOT
iShares Core S&P Total U.S. Stock Market ETF
|
ETF | BlackRock / iShares | 0.00% | $1,431,231.60 | 22,664 | Mar 31, 2026 | May 28, 2026 |
Advertisement (320x50)